Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 20/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2457327 | 0.89 | PDE10A (0.67) | PDE10A | |
| SCHEMBL3317800 | 0.73 | PDE10A (0.80) | PDE10A | |
| SCHEMBL13330676 | 0.72 | PDE10A (0.67) | PDE10A | |
| SCHEMBL2463775 | 0.70 | PDE10A (1.00) | PDE10A | |
| SCHEMBL2486491 | 0.69 | PDE10A (1.00) | PDE10A | |
| SCHEMBL2458552 | 0.69 | PDE10A (1.00) | PDE10A | |
| SCHEMBL2485342 | 0.68 | — | — | |
| SCHEMBL2458740 | 0.67 | PDE10A (1.00) | PDE10A | |
| SCHEMBL2461584 | 0.66 | PDE10A (1.00) | PDE10A | |
| SCHEMBL1304261 | 0.66 | PDE10A (0.76) | PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2364306-A1 | Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors | Amgen Inc. (US) | 2011-09-14 | — | — | EP | claimed |
| WO-2010057126-A1 | PYRIDINE AND PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS | AMGEN INC. (US) | 2010-05-20 | — | — | WO | claimed |
| EP-2364306-A1 | Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors | Amgen Inc. (US) | 2011-09-14 | — | — | EP | disclosed |
| WO-2010057126-A1 | PYRIDINE AND PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS | AMGEN INC. (US) | 2010-05-20 | — | — | WO | disclosed |